CN105793278A - 肽基甘氨肽α酰胺化单氧加氧酶(PAM)用于C端酰胺化的用途 - Google Patents

肽基甘氨肽α酰胺化单氧加氧酶(PAM)用于C端酰胺化的用途 Download PDF

Info

Publication number
CN105793278A
CN105793278A CN201480066822.8A CN201480066822A CN105793278A CN 105793278 A CN105793278 A CN 105793278A CN 201480066822 A CN201480066822 A CN 201480066822A CN 105793278 A CN105793278 A CN 105793278A
Authority
CN
China
Prior art keywords
polypeptide
pam
nucleic acid
amidatioon
pyy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480066822.8A
Other languages
English (en)
Chinese (zh)
Inventor
E·霍夫曼
G·蒂芬塔勒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN105793278A publication Critical patent/CN105793278A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/003General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by transforming the C-terminal amino acid to amides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y114/00Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/17Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced ascorbate as one donor, and incorporation of one atom of oxygen (1.14.17)
    • C12Y114/17003Peptidylglycine monooxygenase (1.14.17.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y403/00Carbon-nitrogen lyases (4.3)
    • C12Y403/02Amidine-lyases (4.3.2)
    • C12Y403/02005Peptidylamidoglycolate lyase (4.3.2.5)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201480066822.8A 2013-12-20 2014-12-10 肽基甘氨肽α酰胺化单氧加氧酶(PAM)用于C端酰胺化的用途 Pending CN105793278A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13199222.4 2013-12-20
EP13199222 2013-12-20
PCT/EP2014/077143 WO2015091131A1 (en) 2013-12-20 2014-12-10 Use of peptidylglycine alpha-amidating monooxigenase (pam) for c-terminal amidation

Publications (1)

Publication Number Publication Date
CN105793278A true CN105793278A (zh) 2016-07-20

Family

ID=49885043

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480066822.8A Pending CN105793278A (zh) 2013-12-20 2014-12-10 肽基甘氨肽α酰胺化单氧加氧酶(PAM)用于C端酰胺化的用途

Country Status (10)

Country Link
US (1) US20160333386A1 (ja)
EP (1) EP3083662A1 (ja)
JP (1) JP2017507645A (ja)
KR (1) KR20160098278A (ja)
CN (1) CN105793278A (ja)
BR (1) BR112016012325A2 (ja)
CA (1) CA2928927A1 (ja)
MX (1) MX2016007202A (ja)
RU (1) RU2016129516A (ja)
WO (1) WO2015091131A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4110372A1 (en) * 2020-02-26 2023-01-04 PAM Theragnostics GmbH Use of peptidylglycine alpha-amidating monooxygenase (pam) for therapeutic purpose
EP4111201A1 (en) * 2020-02-26 2023-01-04 PAM Theragnostics GmbH Methods for determining peptidylglycine alpha-amidating monooxygenase (pam) and its use for diagnostic purpose

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8660701A1 (es) * 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
US8008453B2 (en) * 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
ES2583259T3 (es) * 2009-12-01 2016-09-20 Novo Nordisk A/S Nuevas liasas alfa-amidantes de peptidil alfa-hidroxiglicina

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KAYOKO TATEISHI等: "Isolation and functional expression of human pancreatic peptidylglycine α-amidating monooxygenase", 《BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS》 *
KEN-ICHIRO TAKAHASHI等: "Production of Bioactive Salthe Nonendocrine Cell Lines COS-7 and CHOmon Calcitonin From", 《PEPTIDES》 *
ZHEN LIU等: "Cloning, Co-Expression with an Amidating Enzyme, and Activity of the Scorpion Toxin BmK ITa1 cDNA in Insect Cells", 《MOLECULAR BIOTECHNOLOGY》 *

Also Published As

Publication number Publication date
RU2016129516A (ru) 2018-01-25
BR112016012325A2 (pt) 2017-09-26
MX2016007202A (es) 2016-07-21
US20160333386A1 (en) 2016-11-17
JP2017507645A (ja) 2017-03-23
KR20160098278A (ko) 2016-08-18
CA2928927A1 (en) 2015-06-25
EP3083662A1 (en) 2016-10-26
WO2015091131A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
JP4860702B2 (ja) ポリペプチドのリコンビナント発現のための方法
US20080286834A1 (en) Leader Sequences For Directing Secretion of Polypeptides and Methods For Production Thereof
US20060183163A1 (en) Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement
AU2021203496A1 (en) Super versatile method for presenting cyclic peptide motif on protein structure
AU2016227621B2 (en) System for the presentation of peptides on the cell surface
JP2021508043A (ja) 新規抗原結合部分の特異性試験のためのユニバーサルレポーター細胞アッセイ
RU2714153C2 (ru) СПОСОБ ОТБОРА АНТИТЕЛ С МОДИФИЦИРОВАННЫМ ВЗАИМОДЕЙСТВИЕМ С FcRn
CN109666699B (zh) 一种基于lag-3/mhc ii阻断功能及其生物效应的药物快速筛选方法
CN105793278A (zh) 肽基甘氨肽α酰胺化单氧加氧酶(PAM)用于C端酰胺化的用途
JP2021508246A (ja) 新規抗原結合部分の特異性試験のためのcar−t細胞アッセイ
CN110777148B (zh) 用于表达fgf-2的dna序列和制备fgf-2的方法
JP7462578B2 (ja) プログラム可能な免疫細胞受容体複合体システム
US7566685B2 (en) Methods and compositions for screening using diphtheria toxin constructs
Wolf et al. The ring size of monocyclic ET‐1 controls selectivity and signaling efficiency at both endothelin receptor subtypes
JP2003513670A (ja) ジフテリア毒素構築体を用いるスクリーニングのための方法および組成物
CN110777165B (zh) 增强子序列和质粒载体及其制备方法和应用与转化体
CN116615462A (zh) 抗体构建体的表达技术
US9012602B2 (en) Macaca fascicularis CCL17
JP2007508806A (ja) 新規治療融合タンパク質
WO2022144556A1 (en) Mhc: peptide complexes
WO2024115740A1 (en) Compound for use as a peptide binder specifically binding to the ubiquitin ligase adapter fbxo31
CN112673109A (zh) 细胞选择方法
NZ761205B2 (en) Highly versatile method of presenting cyclic peptide on protein structure
KR20000059761A (ko) 핵수용체 단백질의 전사활성 조절 방법 및 이에 유용한 물질을 스크리닝하는 방법
EP1544307A1 (en) LAC9 chimeric receptor and uses thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1226749

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160720

WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1226749

Country of ref document: HK